Drugmakers struggle to find immunotherapy combos for cancer – Financial Times
Financial Times |
Drugmakers struggle to find immunotherapy combos for cancer
Financial Times Incyte, a US biotech group, had hoped to prove that combining its experimental immunotherapy with Keytruda — a leading checkpoint inhibitor made by its Big Pharma partner Merck — would boost survival rates in patients suffering from melanoma and … |
